NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
23.44
-0.55 (-2.27%)
At close: Jul 24, 2025, 4:00 PM
23.39
-0.04 (-0.19%)
After-hours: Jul 24, 2025, 5:08 PM EDT

NAMS Revenue

NewAmsterdam Pharma Company had revenue of $2.98M in the quarter ending March 31, 2025, with 112.56% growth. This brings the company's revenue in the last twelve months to $47.14M, up 586.97% year-over-year. In the year 2024, NewAmsterdam Pharma Company had annual revenue of $45.56M with 223.37% growth.

Revenue (ttm)
$47.14M
Revenue Growth
+586.97%
P/S Ratio
50.26
Revenue / Employee
$693,235
Employees
68
Market Cap
2.63B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202445.56M31.47M223.37%
Dec 31, 202314.09M-88.60M-86.28%
Dec 31, 2022102.69M--
Dec 31, 2021---
Dec 31, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
Novartis AG55.19B
AstraZeneca54.98B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings